Cranial nerve palsy

Summary

Cranial nerve palsy (MONDO:0002782) is a disease (an umbrella term covering 7 Mondo subtypes) and 2 clinical trials. A subtype of cranial nerve neuropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 7 Mondo subtypes
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cranial nerve palsy
Mondo ID	MONDO:0002782
EFO	EFO:0009489
DOID	DOID:3817
NCIT	C26941
UMLS	C0151311
MedGen	57717
Is cancer (heuristic)	no

Also known as: cranial nerve palsy · cranial nerve paralysis

Disease family

This is a subtype of cranial nerve neuropathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › cranial nerve neuropathy › cranial nerve palsy

Related subtypes (16): vestibulocochlear nerve disorder, ocular motility disease, hypoglossal nerve disorder, facial nerve disorder, optic nerve disorder, cranial nerve neoplasm, accessory nerve disorder, glossopharyngeal nerve disorder, olfactory nerve disorder, trigeminal nerve disorder, third cranial nerve disorder, pseudobulbar palsy, trochlear nerve disorder, jaw-winking syndrome, cranial neuralgia, abducens nerve disorder

Subtypes (7): fourth cranial nerve palsy, oculomotor nerve paralysis, multiple cranial nerve palsy, glossopharyngeal nerve paralysis, Bell’s palsy, abducens nerve palsy, progressive bulbar palsy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02978911	Not specified	RECRUITING	Cranial Nerves Tractography
NCT03206541	Not specified	COMPLETED	Neurologic Manifestations of the Arbovirus Infection in Colombia